Aqueous proteins help predict the response of patients with neovascular age-related macular degeneration to anti-VEGF therapy

BACKGROUND: To reduce the treatment burden for patients with neovascular age-related macular degeneration (nvAMD), emerging therapies targeting vascular endothelial growth factor (VEGF) are being designed to extend the interval between treatments, thereby minimizing the number of intraocular injecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Xuan, Sanchez, Jaron Castillo, Dinabandhu, Aumreetam, Guo, Chuanyu, Patel, Tapan P., Yang, Zhiyong, Hu, Ming-Wen, Chen, Lijun, Wang, Yuefan, Malik, Danyal, Jee, Kathleen, Daoud, Yassine J., Handa, James T., Zhang, Hui, Qian, Jiang, Montaner, Silvia, Sodhi, Akrit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759792/
https://www.ncbi.nlm.nih.gov/pubmed/34874918
http://dx.doi.org/10.1172/JCI144469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759792/
https://www.ncbi.nlm.nih.gov/pubmed/34874918
http://dx.doi.org/10.1172/JCI144469

Ejemplares similares